• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, August 27, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

New guideline decreases breast cancer re-operation rates

Bioengineer by Bioengineer
April 10, 2019
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Patients can avoid added stress and potential surgical complications

IMAGE

Credit: UBC Okanagan photo

A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.

Alex Monaghan, a second-year Southern Medical Program (SMP) student at UBC Okanagan, recently completed a study using patient data from BC Cancer-Kelowna. His research compared re-operation rates for breast cancer patients before and after a new surgical guideline was introduced five years ago.

Breast-conserving surgery (BCS) and radiation therapy is a common first step in treating early-stage breast cancer. Following BCS, the removed portion of a woman’s breast is inked with permanent dye to allow doctors to measure the amount of healthy tissue surrounding a tumour and to determine whether the surgery was adequate.

Historically, debate has centred on the desired amount or margin of space between the tumour and inked edges to optimize patient outcome. With a lack of consensus, re-operation rates as reported by North America public-health institutions have varied considerably between 17 to 35 per cent.

In 2014, the Society of Surgical Oncology and American Society for Radiation Oncology released the new guideline of ‘no tumour on ink’ for cancer patients undergoing BCS.

“The guideline states that if a tumour does not touch the inked portion of tissue, re-operation may not be warranted,” says Monaghan lead author of the study. “Further surgery can lead to increased risk of medical complications and worsened cosmetic effects, without any evidence of prolonged survival or decreased cancer recurrence.”

Monaghan compared data of more than 1,100 patients from 2011 to 2017 to measure re-operation rates before and after the guidelines came into practice. As the primary referral centre for Interior Health, BC Cancer-Kelowna services 10 regional hospitals across the BC Interior. He conducted his research under the guidance of Dr. Christopher Baliski, a surgical oncologist at Kelowna General Hospital and BC Cancer, as well as an SMP clinical assistant professor.

Based on his findings, Monaghan found that a woman with early-stage breast cancer is 72 per cent less likely to have a re-operation after a lumpectomy today compared to 2014 and earlier.

“The research shows how the guideline has been adopted by community surgeons across the BC Interior,” says Monaghan. “Patients can avoid potential surgical complications, added stress, and the cosmetic effects are minimized. In addition, healthcare costs are reduced as a whole.”

Monaghan presented his work at the 105th meeting of the North Pacific Surgical Association in November of 2018. The study, supported by BC Cancer’s Surgical Oncology Network, was published recently in the American Journal of Surgery.

###

Media Contact
Patty Wellborn
[email protected]

Original Source

https://news.ok.ubc.ca/2019/04/10/new-guideline-decreases-breast-cancer-re-operation-rates

Related Journal Article

http://dx.doi.org/10.1016/j.amjsurg.2019.01.007

Tags: Breast CancercancerHealth ProfessionalsMedicine/HealthMicrobiologyMolecular PhysicsNuclear PhysicsSurgery
Share12Tweet8Share2ShareShareShare2

Related Posts

Exploring Fungal Diversity via Metabarcoding Techniques

Exploring Fungal Diversity via Metabarcoding Techniques

August 27, 2025
METTL3-Driven m6A Boosts Sorafenib’s Antitumor Effects

METTL3-Driven m6A Boosts Sorafenib’s Antitumor Effects

August 27, 2025

Immune Cells in the Brain: Crucial Architects of Adolescent Neural Wiring

August 26, 2025

Dihydromyricetin Shields Against Spinal Cord Injury Damage

August 26, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    148 shares
    Share 59 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Carrier-Free Nanomedicines: Innovations and Challenges Ahead

Optimizing Pulsed Electromagnetic Fields for Knee Osteoarthritis Treatment

Health Policy Document Positioning: Key Research Insights

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.